Emergency pharmacy - jynarque
Ended Awarded
- Contract number
- 36C26124N0761
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $50,323
Award facts
- Contract value 100% obligated
- $50,332.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21), awarded a $50,332.88 firm fixed-price delivery order to Otsuka America Pharmaceutical Inc. on July 8, 2024, with an ultimate completion date of July 23, 2024. This delivery order procures Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. The contract was issued without a set-aside designation and is being performed in Potomac, Maryland. This delivery order is issued under the parent Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and leverages Otsuka America's existing Blanket Purchase Agreement with the VA's National Acquisition Center valued at $83.3 million and extending through March 26, 2026.
Otsuka America Pharmaceutical Inc., a Rockville, Maryland-based pharmaceutical manufacturer, is a primary supplier of specialty drugs to the VA through its Federal Supply Schedule contract portfolio. The company has established a significant presence within the VA healthcare system, regularly fulfilling delivery orders across multiple Veterans Integrated Service Networks for Jynarque in various dosages. This particular delivery order supports VISN 21's mission to provide specialized pharmaceutical treatments to veterans and reflects the VA's streamlined procurement approach for critical medications through existing indefinite delivery vehicles, enabling efficient access to complex pharmaceutical therapies across the veteran population.
Quick answers
Who was awarded contract 36C26124N0761?
36C26124N0761 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on July 8, 2024.
How much is contract 36C26124N0761 worth?
The government has obligated $50,323 on 36C26124N0761. Its current value, with exercised options, is $50,333.
Is contract 36C26124N0761 an order under another contract?
Yes. 36C26124N0761 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0761 competed?
The extent of competition for 36C26124N0761 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award